PURCHASE, N.Y.--(BUSINESS WIRE)--Teladoc, Inc. (NYSE: TDOC), the first and largest telehealth platform in the United States, will release its third quarter operating results on Monday, November 2, 2015 after market close, with a conference call to follow at 5 p.m. EST.
Stockholders and interested participants may listen to a live broadcast of the conference call by dialing 877-201-0168 or 647-788-4901 for international callers, and referencing participant code 56728128 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the company’s web site and an audio file of the call will also be archived for 90 days at ir.teladoc.com. After the conference call, a replay will be available until November 16, 2015 and can be accessed by dialing 855-859-2056 or 404-537-3406 for international callers, and referencing participant code 56728128.
Teladoc, Inc. (NYSE: TDOC) is the nation’s first and largest telehealth platform, delivering on-demand health care anytime, from almost anywhere via mobile devices, the internet, secure video and phone. More than 12.5 million U.S. members are connected to Teladoc’s network of over 2,000 board-certified, state-licensed physicians and behavioral health professionals who provide care for a wide range of non-emergency conditions. With a median response time of less than 10 minutes, Teladoc physicians will perform more than 525,000 telehealth visits in 2015. Teladoc and its physicians consistently earn a 95 percent member satisfaction rating or better, and Teladoc is the only telehealth company to be certified by the National Committee for Quality Assurance (NCQA) for its physician credentialing process.
Recognized by MIT Technology Review as one of its "50 Smartest Companies 2015,” Teladoc works with health plans, employers, organizations and individuals to provide access to affordable, high-quality health care on demand. Teladoc is transforming the access, cost and quality dynamics of health care delivery. For more information, visit please teladoc.com, twitter.com/teladoc, facebook.com/teladoc or linkedin.com/teladoc.